4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Century Therapeutics, Inc. (IPSC) operates in the Biotechnology industry and is headquartered in Philadelphia, United States with about 78 employees. Its market capitalization is roughly $406 million. In the fiscal year ended 2025-12-31, IPSC reported $109M in revenue and ($10M) in net income.
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $109M | $7M | $2M | $5M | — |
| Operating Income (EBIT) | ($10M) | ($134M) | ($125M) | ($124M) | — |
| Net Income | ($10M) | ($127M) | ($137M) | ($131M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $109M | — |
| Operating Income (EBIT) | ($24M) | ($21M) | ($29M) | ($35M) | $74M | — |
| Net Income | ($22M) | ($19M) | ($34M) | ($32M) | $77M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $224M | $353M | $361M | $486M | — |
| Total Liabilities | $65M | $192M | $176M | $184M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IPSC viewer.
About TickerBase · Data methodology & sources